Sign in
4

Changes in Ownership

Nuvectis Pharma, Inc. Filed Acc 0001104659-23-107367

Chairman & CEO bought 3,220 shares at an average $11.01 ($35,455)

From the SEC's structured data for this filing

Trades in this filing

BENTSUR RON · Chairman & CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-10-04 Purchase : show line 1 in the form +1,820 $10.95 $19,929 3,234,364 D
2023-10-05 Purchase : show line 2 in the form +1,400 $11.09 $15,526 3,235,764 D
Open-market purchases · 3,220 sh · avg $11.01 · $35,455
Loading xslF345X05/tm2327960-1_4seq1.xml…